JOSHUA WIGDAHL: Open Payments
NPI 1457729097 · DERBY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,516 in 83 payments from 22 companies in 2025. Trend: 2023 $1,127 · 2024 $1,196 · 2025 $1,516
Food & beverage: $1,516
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $223 |
| GlaxoSmithKline, LLC. | 10 | $197 |
| Lilly USA, LLC | 10 | $161 |
| AstraZeneca Pharmaceuticals LP | 7 | $151 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $99 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $84 |
| ABBVIE INC. | 5 | $70 |
| Amgen Inc. | 3 | $53 |
| Vanda Pharmaceuticals Inc. | 2 | $52 |
| Insulet Corporation | 3 | $47 |
Products named: TRELEGY ELLIPTA, XIFAXAN, Wegovy, Kerendia, MOUNJARO, Ozempic, FARXIGA, FANAPT.
Industry payments across KS — which companies pay providers there.
